Crossmark Global Holdings, Inc. - BAXTER INTL INC ownership

BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,124 filers reported holding BAXTER INTL INC in Q2 2020. The put-call ratio across all filers is 0.74 and the average weighting 0.3%.

About BAXTER INTL INC

Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.

Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.

Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.

Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.

Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Quarter-by-quarter ownership
Crossmark Global Holdings, Inc. ownership history of BAXTER INTL INC
ValueSharesWeighting
Q3 2023$995
-21.1%
26,654
-0.7%
0.02%
-14.8%
Q2 2023$1,261
+8.0%
26,836
-6.8%
0.03%0.0%
Q1 2023$1,168
-26.0%
28,781
-7.1%
0.03%
-30.8%
Q4 2022$1,579
-99.9%
30,988
+3.6%
0.04%
-13.3%
Q3 2022$1,610,000
-15.6%
29,903
+0.7%
0.04%
-8.2%
Q2 2022$1,908,000
-16.5%
29,696
+0.7%
0.05%
-3.9%
Q1 2022$2,286,000
-7.7%
29,486
+2.2%
0.05%
-5.6%
Q4 2021$2,477,000
+5.4%
28,857
-1.3%
0.05%
-1.8%
Q3 2021$2,351,000
-2.0%
29,228
-1.9%
0.06%
-1.8%
Q2 2021$2,400,000
-5.0%
29,808
-0.4%
0.06%
-11.1%
Q1 2021$2,525,000
+5.0%
29,938
-0.1%
0.06%
+3.3%
Q4 2020$2,404,000
-0.1%
29,955
+0.1%
0.06%
-9.0%
Q3 2020$2,406,000
-11.3%
29,915
-5.0%
0.07%
-15.2%
Q2 2020$2,711,000
+3.4%
31,485
-2.5%
0.08%
-16.0%
Q1 2020$2,623,000
-38.7%
32,302
-36.8%
0.09%
-19.7%
Q4 2019$4,276,000
-26.6%
51,133
-23.3%
0.12%
-31.2%
Q3 2019$5,829,000
+5.0%
66,642
-1.7%
0.17%
+9.0%
Q2 2019$5,552,000
-5.4%
67,788
-6.1%
0.16%
-6.6%
Q1 2019$5,871,000
+29.3%
72,203
+4.7%
0.17%
+18.4%
Q4 2018$4,539,000
-28.3%
68,965
-16.0%
0.14%
-12.4%
Q3 2018$6,329,000
-2.2%
82,096
-6.3%
0.16%
-7.5%
Q2 2018$6,470,000
+40.6%
87,617
+23.8%
0.17%
+46.2%
Q1 2018$4,602,000
-10.0%
70,754
-10.5%
0.12%
-3.3%
Q4 2017$5,111,000
+52.1%
79,076
+47.7%
0.12%
+41.4%
Q3 2017$3,361,0000.0%53,5540.0%0.09%0.0%
Q3 2016$3,361,00053,5540.09%
Other shareholders
BAXTER INTL INC shareholders Q2 2020
NameSharesValueWeighting ↓
Tavio Capital LLC 68,405$5,890,0007.81%
Iron Triangle Partners LP 330,000$28,413,0007.16%
Veritas Asset Management LLP 8,942,428$769,943,0005.64%
TSFG, LLC 93,405$8,042,0005.31%
GENERATION INVESTMENT MANAGEMENT LLP 10,606,094$913,185,0005.27%
Third Point 4,000,000$344,400,0004.72%
Avidity Partners Management LP 800,900$68,957,0004.42%
Palmer Knight Co 62,275$5,362,0004.17%
Eos Focused Equity Management, L.P. 36,786$3,167,0003.70%
Dundas Partners LLP 196,133$16,887,0003.69%
View complete list of BAXTER INTL INC shareholders